Comparing how effective and safe 14 days and 28 days of inhaled aztreonam were at getting rid of a Pseudomonas bacterial lung infection.
STOP Codon mutations are associated with more severe disease from childhood in people with cystic fibrosis
Molecular fingerprinting of Pseudomonas aeruginosa from PWCF, and a UK reference laboratory investigation into frequency of cross-infection
Ivacaftor impacts nutrition and growth status in 4 to 24 month old children within the first 12 weeks
Successful treatment of a blockage in the lower portion of the small intestine in patients with cystic fibrosis using a solution administered during a colonoscopy.
